Related content

The Promise of Personalized Medicines Versus Potential for Abuse: Ethical Issues in Pharmacogenetics

By  

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 3, 2004-01 ,pp. : 3-7

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations

By Krekels Elke HJ   Anker John N van den   Baiardi Paola   Cella Massimo   Cheng Katharine Y   Gibb Diana M   Green Hannah   Iolascon Achille   Jacqz-Aigrain Evelyne M   Knibbe Catherijne AJ   Santen Gijs WE   Schaik Ron HN van   Tibboel Dick   Pasqua Oscar E Della  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1787-1799

Informa Healthcare

Access to resources Recommend Favorite

Herbal Medicines for the Management of Opioid Addiction: Safe and Effective Alternatives to Conventional Pharmacotherapy?

By Ward Jeanine  

CNS Drugs, Vol. 25, Iss. 12, 2011-12 ,pp. : 999-1007

Adis International

Access to resources Recommend Favorite

Discovery and development of selective PPARγγ modulators as safe and effective antidiabetic agents

By Doshi Lalit S   Brahma Manoja Kumar   Bahirat Umakant A   Dixit Amol V   Nemmani Kumar VS  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 489-512

Informa Healthcare

Access to resources Recommend Favorite

Development of New H1 Antihistamines: The Importance of Pharmacokinetics in the Evaluation of Safe and Therapeutically Effective Agents

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 5, 2005-10 ,pp. : 451-464

Bentham Science Publishers

Access to resources Recommend Favorite